BERNARDI, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.054
AS - Asia 3.961
EU - Europa 2.034
SA - Sud America 601
Continente sconosciuto - Info sul continente non disponibili 125
AF - Africa 104
OC - Oceania 5
Totale 15.884
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 8.848
SG - Singapore 1.186
HK - Hong Kong 817
CN - Cina 684
VN - Vietnam 456
BR - Brasile 432
GB - Regno Unito 373
IT - Italia 353
BD - Bangladesh 302
SE - Svezia 296
FI - Finlandia 261
RU - Federazione Russa 175
DE - Germania 119
KR - Corea 113
CA - Canada 101
BG - Bulgaria 92
FR - Francia 73
IN - India 69
AR - Argentina 66
NL - Olanda 47
JP - Giappone 44
IQ - Iraq 41
ID - Indonesia 39
AE - Emirati Arabi Uniti 37
ZA - Sudafrica 37
MX - Messico 34
PL - Polonia 31
UA - Ucraina 30
IE - Irlanda 28
TR - Turchia 27
AT - Austria 25
CO - Colombia 24
BE - Belgio 23
PK - Pakistan 23
ES - Italia 22
CL - Cile 19
EC - Ecuador 17
LT - Lituania 15
MY - Malesia 14
VE - Venezuela 14
CZ - Repubblica Ceca 13
DZ - Algeria 13
EG - Egitto 13
SA - Arabia Saudita 13
CR - Costa Rica 12
PY - Paraguay 12
HN - Honduras 11
JM - Giamaica 10
KE - Kenya 10
UZ - Uzbekistan 10
IL - Israele 9
IR - Iran 9
KZ - Kazakistan 9
MA - Marocco 9
PH - Filippine 9
GT - Guatemala 8
AZ - Azerbaigian 7
ET - Etiopia 7
JO - Giordania 7
NO - Norvegia 7
RO - Romania 7
UY - Uruguay 7
DO - Repubblica Dominicana 6
PE - Perù 6
TN - Tunisia 6
CH - Svizzera 5
DK - Danimarca 5
NI - Nicaragua 5
NP - Nepal 5
RS - Serbia 5
AU - Australia 4
BO - Bolivia 4
BY - Bielorussia 4
EE - Estonia 4
SV - El Salvador 4
TT - Trinidad e Tobago 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
HU - Ungheria 3
KG - Kirghizistan 3
LB - Libano 3
LK - Sri Lanka 3
MD - Moldavia 3
OM - Oman 3
PR - Porto Rico 3
SC - Seychelles 3
TH - Thailandia 3
BS - Bahamas 2
CY - Cipro 2
GE - Georgia 2
GR - Grecia 2
LV - Lettonia 2
MK - Macedonia 2
PS - Palestinian Territory 2
PT - Portogallo 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
AM - Armenia 1
AO - Angola 1
Totale 15.743
Salva come PNG Salva come JPEG
Città #
Santa Clara 1.185
Ashburn 1.071
Hong Kong 808
Singapore 771
Fairfield 552
Chandler 548
San Jose 469
Council Bluffs 263
Helsinki 255
Nyköping 255
London 221
Woodbridge 209
Houston 201
Wilmington 196
Seattle 168
Cambridge 159
Beijing 153
Los Angeles 152
New York 149
Ann Arbor 148
Ho Chi Minh City 140
The Dalles 124
Hanoi 116
San Diego 116
Boardman 115
Chicago 111
Seoul 109
Sunnyvale 92
Princeton 91
Sofia 91
Oakland 77
Buffalo 67
Hefei 60
Milan 60
Orem 55
Salt Lake City 52
Dallas 48
Moscow 47
São Paulo 45
Shanghai 42
Southend 41
North Bergen 37
Jersey City 34
Bremen 33
Phoenix 32
Tokyo 30
Dearborn 28
Da Nang 27
Dublin 26
Rome 26
Toronto 26
Atlanta 25
Tampa 24
Brussels 23
Johannesburg 23
Haiphong 22
Jakarta 22
Warsaw 22
Chennai 21
Redondo Beach 21
Saint Augustine 21
Reading 20
Washington 20
Brooklyn 19
San Francisco 19
Frankfurt am Main 18
Amsterdam 17
Montreal 15
Bologna 14
Elk Grove Village 14
Jacksonville 14
Mexico City 14
Miano 14
Newark 14
Philadelphia 14
Rio de Janeiro 14
Denver 13
Detroit 13
Groningen 13
Lauterbourg 13
Manchester 13
Paris 13
Vienna 13
Biên Hòa 12
Brno 12
Miami 12
Stockholm 12
West Bloomfield 12
Des Moines 11
Las Vegas 11
Norwalk 11
Charlotte 10
Falkenstein 10
Nairobi 10
North Charleston 10
Pittsburgh 10
Vancouver 10
Baghdad 9
Belo Horizonte 9
Buenos Aires 9
Totale 10.666
Salva come PNG Salva come JPEG
Nome #
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 395
A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18. 348
AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions 336
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 303
Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool 296
Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice 289
Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation 272
Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B 264
Adaptive response in Hepatitis B virus infection 262
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 255
Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report 238
Alcohol and viral hepatitis: a mini-review 236
A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of non-responder patients with chronic hepatitic C 233
C-11 Acetate does not enhance usefulness of F-18 FDG PET/CT in differentiating between focal nodular hyperplasia and hepatic adenoma 233
CD 133+ stem cells for the treatment of end stage liver disease 226
Development of different psychiatric manifestations during antiviral therapy for chronic hepatitis C. 225
A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis 220
Comparing and combining gamma-hydroxybutiric acid (GHB) and naltrexone in maintaining abstinence from alcohol: an open randomized comparative study 218
Chronic hepatitis B: Are we close to a cure? 211
Acquired intestinal lymphangiectasia successfully treated with a low fat and MCT-enriched diet in a patient with liver transplantation 210
Allocation priority in non urgent liver transplantation: an overview of proposed scoring systems 205
MARS and Prometheus: our clinical experience in acute chronic liver failure 200
Characterization of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver 198
In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C 196
Stem cell mobilization and collection in patients with liver cirrhosis 196
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C 194
Liver transplantation for patients with alcoholic liver disease: an open question 193
Calcineurin inhibitors levels reduction during treatment with Sofosbuvir in liver transplanted patients 191
An in-depth psychosocial and biochemical evaluation in transplant recipients for alcoholic liver disease should be planned 191
In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with eAg-negative chronic hepatitis B 190
Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft 190
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 185
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 179
Surveillance for hepatocellular carcinoma in elderly italian patients with cirrhosis. Effects on cancer staging and patients survival 177
Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy 176
Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection 175
Is female sex a significant favorable prognostic factor in hepatocellular carcinoma? 175
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 173
Serum hepatitis B surface antigen monitoring in long-term Lamivudine-treated hepatitis B virus patients 172
Bone marrow derived stem cells for the treatment of end-stage liver disease 172
Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naive and non-responder patients on a stable immunosuppressive regimen 171
Relationship between hepatic hemodynamics assessed by Doppler ultrasound and liver stiffness 169
Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report 165
Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection 165
Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection 163
Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: which is the winner? 161
Hepatitis B virus and immune response 160
The increase of Ribavirin dose improves sustained virological response in HCV-Genotype 1 patients with a partial response to PEG-Interferon and Ribavirin. 160
Ketoprofen, peginterferon-alpha2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study 159
Hepatitis C in the elderly: a multicenter cross-sectional study by the Italian Association for the Study of the Liver 159
Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C 159
Trattamento dell’epatopatia alcolica 157
Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation 154
Review article: Alcoholic liver disease - Pathophysiological aspects and risk factors 154
Role of Contrast-Enhanced Ultrasonography in Primary Hepatic Lymphoma 152
Vitamin E for the treatment of E-antigen-positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study 150
Immunological modifications during treatment with thymosin alpha 1 plus antiviral therapy in chronic hepatitis C 148
Hepatocellular carcinoma in patients with cryptogenic cirrhosis 147
Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholi fatty liver disease: an Italian community-based population study 146
The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis 146
Genetic heterogeneity of hepatitis C virus in HBV/HCV co-infection 145
Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case controlled study 143
Virological analysis, genotypes and mutational patterns of the HBV pre-core/core gene in HBV/HCV-related hepatocellular carcinoma 143
Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: a phase I clinical trial 142
Human herpesvirus-8-related Kaposi’s sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin 142
Hepatocellular carcinoma appearance in patients with hepatitis C virus-related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin 140
High incidence of allograft dysfunction in liver transplant patients treated with PEG-Interferon alfa-2b and Ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? 140
Two yr mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction after liver transplant 138
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 137
Thymosin-alpha 1 plus interferon-alpha for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial 137
High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing Lamivudine resistance 128
MUTATIONAL ANALYSIS OF THE HBV PRE-CORE/CORE GENE IN HBV/HCV-RELATED HEPATOCELLULAR CARCINOMA 126
Hepatitis C Virus-related chronic liver disease in elderly patients: an Italian cross-sectional study 125
Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection 124
Vitamins in the treatment of chronic viral hepatitis 124
Effect of liver transplantation on tuftsin activity and phagocytic activity of neutrophyl granulocytes in patients with liver cirrhosis 124
Post-transplantation lymphoproliferative disorders in liver transplanted patients: a report of four cases 121
ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS 120
GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS) 119
Stem cells for end stage liver disease: How far have we got? 119
Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis 117
Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses 115
In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death 114
OUTCOME OF LIVER TRANSPLANT FOR ALCOHOLIC LIVER DISEASE 113
Sustained and focused HBV-nucleocapsid-specific T cell immunity in liver transplant recipients compared to individuals with chronic and self-limited HBV infection 112
Hepatic artery stenosis in liver transplanted patients treated with pegylated Interferon alpha-2b and Ribavirin 111
Evolution of hepatitis C vitus non structural 5A gene (NS5A) in the progression of liver disease to hepatocellular carcinoma 110
PEGYLATED INTERFERON PLUS RIBAVIRIN FOR THE TREATMENT OF RECURRENT HCV INFECTION AFTER LIVER TRANSPLANTATION 109
Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study 108
Vitamin E as treatment for chronic viral hepatitis: is it time to perform large clinical trials? 95
Totale 15.884
Salva come PNG Salva come JPEG
Categoria #
all - tutte 79.709
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 79.709
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.045 0 0 0 25 11 86 90 85 207 185 193 163
2022/20231.378 188 174 101 137 160 225 11 126 174 4 44 34
2023/2024778 26 47 33 79 217 22 44 122 28 18 28 114
2024/20253.171 117 23 6 238 839 492 116 252 327 178 221 362
2025/20265.940 260 114 387 630 831 439 716 441 576 581 484 481
2026/20271.892 231 663 419 579 0 0 0 0 0 0 0 0
Totale 15.884